Solana (SOL) has lower chances of being affected by the potential supply pressure from Grayscale's influence compared to Litecoin (LTC) if the Securities and Exchange Commission (SEC) approves altcoin exchange-traded funds (ETFs).Solana (SOL) has lower chances of being affected by the potential supply pressure from Grayscale's influence compared to Litecoin (LTC) if the Securities and Exchange Commission (SEC) approves altcoin exchange-traded funds (ETFs).

Long Solana, Short Litecoin trade attractive if altcoin ETFs are approved: K33

3 min read
  • A long Solana, short Litecoin trading strategy could be attractive if altcoin ETFs gain SEC approval.
  • Grayscale's SOL trust represents 0.1% of Solana's circulating supply and has never traded below its net asset value.
  • The firm's LTC trust comprises 2.65% of Litecoin's circulating supply and has often traded at steep discounts to its underlying assets.

Solana (SOL) has lower chances of being affected by the potential supply pressure from Grayscale's influence compared to Litecoin (LTC) if the Securities and Exchange Commission (SEC) approves altcoin exchange-traded funds (ETFs).

Solana and Litecoin ETFs fuel deliberation ahead of SEC decision

Solana and Litecoin could see diverging investor sentiment if the SEC approves altcoin ETFs, noted Vetle Lunde, Head of Research at K33, in a Tuesday report.

Lunde noted that a "long SOL, short LTC" trade may be attractive if altcoin ETFs are launched, citing the differences in the trading histories of Grayscale's Solana and Litecoin trusts.

The firm's Solana trust, which began trading in 2023, represents only 0.1% of the circulating SOL supply and has never traded below its net asset value (NAV). K33 noted that this removes the risk of excess supply hitting the market if Grayscale's SOL trust is converted into an ETF.

On the other hand, the Grayscale Litecoin trust, which went public earlier than its Solana counterpart, traded at steep discounts during the 2022 bear market and for most of 2025.

Lunde highlighted that Grayscale holds a large portion of LTC's circulating supply — 2.65%. Given its history of occasionally trading at discounts, the firm's Litecoin trust could experience significant outflows upon conversion to an ETF.

"We see a long SOL, short LTC trade as attractive after ETF launches, assuming they occur around the same time. Given LTC's history of sharp reactions to positive news, we'll likely wait a few days post-launch before acting."

Grayscale SOL & LTC Trusts. Source: K33 Research

Intense outflows from Grayscale Bitcoin and Ethereum trusts also pressured BTC and ETH ETFs during their respective launches last year. However, inflows into several other products were able to offset outflows from Grayscale to a large extent.

Unlike Bitcoin and Ethereum ETFs, Grayscale is one of the only three issuers, alongside Canary Capital and CoinShares, that have filed for an LTC ETF, "meaning fewer issuers are present to offset the potential outflows," the report states.

The prediction from K33 comes as the US Securities and Exchange Commission (SEC) approved generic listing standards for crypto ETFs. The regulator is also expected to make a decision on Litecoin and Solana ETF filings in early October, before deciding on other funds later in the month.

Solana and Litecoin trade around $210 and $107, down 2% and up 0.1%, respectively, over the past 24 hours.


Market Opportunity
Polytrade Logo
Polytrade Price(TRADE)
$0.03723
$0.03723$0.03723
-9.78%
USD
Polytrade (TRADE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29